Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Dat C, Pham"'
Autor:
Shivam M. Kharod, MD, R.Charles Nichols, MD, Randal H. Henderson, MD, MBA, Christopher G. Morris, MS, Dat C. Pham, MD, Vandana K. Seeram, MBBS, Lisa M. Jones, MD, Maria Antonio-Miranda, MD, Daniel A. Siragusa, MD, Zuofeng Li, DSc, Stella Flampouri, PhD, MSc, Bradford S. Hoppe, MD, MPH
Publikováno v:
International Journal of Particle Therapy, Vol 7, Iss 2, Pp 1-10 (2020)
Purpose: Due to the excellent outcomes with image-guided stereotactic body radiotherapy for patients with early-stage non–small cell lung cancer (NSCLC) and the low treatment-related toxicities using proton therapy (PT), we investigated treatment o
Externí odkaz:
https://doaj.org/article/be204a5aa19b43449b4e30ecf3ffe4a1
Autor:
Bradford S. Hoppe, Romaine C. Nichols, Stella Flampouri, Mark Pankuch, Christopher G. Morris, Dat C. Pham, Pranshu Mohindra, William F. Hartsell, Nasiruddin Mohammed, Brian H. Chon, Larry L. Kestin, Charles B. Simone
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 113:732-741
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b75bd94bc2576fa80f5b1ced70daf4b
https://doi.org/10.1016/j.ijrobp.2022.03.005
https://doi.org/10.1016/j.ijrobp.2022.03.005
Autor:
Keri Hopper, Nancy P. Mendenhall, Anamaria R. Yeung, Kathryn E. Hitchcock, Julie A. Bradley, Dat C. Pham, Bradford S. Hoppe, John W. Hiemenz, Sarah M Rausch-Osian, Jennifer C King, Alexandra Sierra, Jana Wieland, Lisa Jones
Publikováno v:
International Journal of Particle Therapy. 6:42-49
Purpose: Treatment success in lung cancer is no longer restricted to objective measures of disease-specific outcomes and overall survival alone but now incorporates treatment morbidity and subjective quality of life (QoL). This study reports how lung
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::374330061653d247b687118f8335c4b1
https://doi.org/10.14338/ijpt-19-00072.1
https://doi.org/10.14338/ijpt-19-00072.1
Autor:
He J Zhu, Dat C. Pham, Lisa Jones, Randal H. Henderson, Bradford S. Hoppe, James Cury, Romaine C. Nichols, Christopher G. Morris, Lisa A. McGee, Stella Flampouri, Christopher Klassen, Vandana Seeram
Publikováno v:
Acta Oncologica. 58:313-319
PURPOSE To investigate the impact of unfavorable risk factors among patients with locally advanced nonsmall cell lung cancer (LA-NSCLC) treated with proton therapy (PT). MATERIAL AND METHODS From May 2008 through July 2015, 90 consecutive patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::add0889c2aa74eef069135012ad38223
https://doi.org/10.1080/0284186x.2018.1546060
https://doi.org/10.1080/0284186x.2018.1546060
Publikováno v:
Cureus
Lung cancer is a worldwide concern and is the leading cause of cancer-related death in the United States. Adenocarcinoma is the most common type of non-small cell lung cancer; however, unlike other types of lung cancer this disease is often seen in l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85f9ecc8b69dc7f8b606b5e989e463cf
https://doi.org/10.7759/cureus.9437
https://doi.org/10.7759/cureus.9437
Autor:
Maria Antonio-Miranda, Christopher G. Morris, Zuofeng Li, Dat C. Pham, Soon Huh, Shivam M Kharod, R. Charles Nichols, Bradford S. Hoppe, Vandana Seeram, Lisa Jones, Randal H. Henderson
Publikováno v:
Acta oncologica (Stockholm, Sweden). 59(10)
The treatment of centrally-located early-stage non-small cell lung cancer (NSCLC) with image-guided stereotactic body radiotherapy (SBRT) is challenging due to the proximity of critical normal structures to the tumor target. The purpose of this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::709f74db6274263dd958c1e246a3de38
https://pubmed.ncbi.nlm.nih.gov/32394776
https://pubmed.ncbi.nlm.nih.gov/32394776
Autor:
S. Flampouri, Zuofeng Li, Maria Antonio-Miranda, Christopher G. Morris, Vandana Seeram, Daniel Siragusa, Bradford S. Hoppe, Lisa Jones, Randal H. Henderson, R. Charles Nichols, Dat C. Pham, Shivam M Kharod
Publikováno v:
International Journal of Particle Therapy, Vol 7, Iss 2, Pp 1-10 (2020)
International Journal of Particle Therapy
International Journal of Particle Therapy
Purpose Due to the excellent outcomes with image-guided stereotactic body radiotherapy for patients with early-stage non–small cell lung cancer (NSCLC) and the low treatment-related toxicities using proton therapy (PT), we investigated treatment ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ea7ecc18f09cd85a333ba21129a7769
https://pubmed.ncbi.nlm.nih.gov/33274252
https://pubmed.ncbi.nlm.nih.gov/33274252
Autor:
Randal H. Henderson, Dat C. Pham, Zuofeng Li, Abubakr A. Bajwa, Harry J. D'Agostino, Bradford S. Hoppe, Barry McCook, Romaine C. Nichols, Soon Huh, Christopher G. Morris, James Cury, S. Flampouri
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 95:517-522
Purpose Proton therapy has been shown to reduce radiation dose to organs at risk (OAR) and could be used to safely escalate the radiation dose. We analyzed outcomes in a group of phase 2 study patients treated with dose-escalated proton therapy with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cffbf70548297e89dc80ceacf5f1b64b
https://doi.org/10.1016/j.ijrobp.2015.11.004
https://doi.org/10.1016/j.ijrobp.2015.11.004
Autor:
Dat C. Pham, Trevanne Matthews Hew, Ian Tfirn, Jason Hew, Hardik Satish Chhatrala, Shiva Gautam, Meet Kadakia
Publikováno v:
Journal of Clinical Oncology. 38:233-233
233 Background: While prostate cancer mortality has declined in the in the general population, it remains high in African Americans. The aim of our study is to determine whether race and insurance type affect treatment outcomes in prostate cancer pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f28117cdd8f5215bf49e0d83d9534fc
https://doi.org/10.1200/jco.2020.38.6_suppl.233
https://doi.org/10.1200/jco.2020.38.6_suppl.233
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports
Journal of Investigative Medicine High Impact Case Reports, Vol 6 (2018)
Journal of Investigative Medicine High Impact Case Reports, Vol 6 (2018)
We report the case of a patient with B-cell prolymphocytic leukemia who was successfully treated with the novel humanized monoclonal antibody obinutuzumab. This patient was previously treated with the combination of rituximab and bendamustine and had
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdefb588dfc9f3736e01edb94fc29e94
https://pubmed.ncbi.nlm.nih.gov/30038912
https://pubmed.ncbi.nlm.nih.gov/30038912